Wed, Jan 28, 2015, 5:12 AM EST - U.S. Markets open in 4 hrs 18 mins


% | $
Quotes you view appear here for quick access.

SciClone Pharmaceuticals, Inc. Message Board

  • usualsuspect9753 usualsuspect9753 Jan 29, 2013 9:19 AM Flag

    Reimbursment Drug List

    Along with the 18% price reduction Zadaxin experienced last September, was the inclusion on the Reimbursement Drug List. RDL. China partially reimburses the cost of many drugs, as well as a few medical devices. To be reimbursed, a drug must be put on China's National Reimbursement Drug List (NRDL). NRDL inclusion can greatly expand the potential market of a drug in China by making it more accessible to middle to lower income consumers. Now, signing a deal for distribution with Sinopharm, the largest pharmaceutical distributor in China, will increase Zadaxins' presence in tier 2 and tier 3 hospitals. Sciclones' deal with their existing distributors last year ended up with a net reduction of only 8%. Sciclone must have made the same deal with Sinopharm. So between access to tier 2&3 hospitals, favorable pricing for patients and inclusion on the RDL, Sciclone is ready for new heights.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Even with the price reduction, Zadaxin costs the patient more than 3 times the cost of thymosin from other producers. The little bit of reimbursement doesn't close this gap by much. To broaden coverage of tier 2 and tier 3 hospitals, SciClone has to increase its sales force to make those calls. Unfortunately, such efforts so far haven't produced much results according to the latest 10-Q.

      Distribution to these hospitals was never the issue, SciClone's old line-up of distributors covered essentially all hospitals in China. But the direct Zadaxin sales force is needed to make the sale. Sinopharm never provided that in the past even though they typically accounted for 50% or more of SciClone's importation of Zadaxin. That doesn't change as far as we know with the exclusivity agreement.

7.370.00(0.00%)Jan 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST
Microsoft Corporation
NASDAQTue, Jan 27, 2015 4:00 PM EST
Horizon Pharma plc
NASDAQTue, Jan 27, 2015 4:00 PM EST